Peter Powchik
Net worth: 161 940 $ as of 2024-03-30
Profile
Peter Powchik's former jobs include being a Senior Medical Director at Sumitomo Pharma America, Inc., a Principal at Pfizer Inc., a VP-Clinical Development & Medical Affairs at Novartis Pharmaceuticals Corp., a Chief Medical Officer & Senior Vice President at Chugai Pharma USA LLC, and a Senior Vice President-Clinical Development at Regeneron Pharmaceuticals, Inc. He also served as the Global Scientific Director, Director & EVP at Vaxxinity, Inc. from 2023 to 2024.
Dr. Powchik obtained a doctorate degree from New York University School of Medicine.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
VAXXINITY INC CLASS A
0.20% | 2023-10-01 | 225,858 ( 0.20% ) | 161 940 $ | 2024-03-30 |
Former positions of Peter Powchik
Companies | Position | End |
---|---|---|
VAXXINITY, INC. | Chief Tech/Sci/R&D Officer | 2024-03-30 |
REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-12-31 |
Chugai Pharma USA LLC
Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Chief Tech/Sci/R&D Officer | 2006-09-30 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Chief Tech/Sci/R&D Officer | 2005-04-30 |
PFIZER, INC. | Corporate Officer/Principal | 2001-03-31 |
Training of Peter Powchik
New York University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
PFIZER, INC. | Health Technology |
REGENERON PHARMACEUTICALS, INC. | Health Technology |
VAXXINITY, INC. | Health Technology |
Private companies | 4 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Chugai Pharma USA LLC
Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Distribution Services |
Chugai Pharma USA, Inc. |
- Stock Market
- Insiders
- Peter Powchik